Tausif Monif

823 total citations
85 papers, 675 citations indexed

About

Tausif Monif is a scholar working on Analytical Chemistry, Pharmacology and Infectious Diseases. According to data from OpenAlex, Tausif Monif has authored 85 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Analytical Chemistry, 27 papers in Pharmacology and 16 papers in Infectious Diseases. Recurrent topics in Tausif Monif's work include Analytical Methods in Pharmaceuticals (30 papers), Antibiotics Pharmacokinetics and Efficacy (22 papers) and Pharmacogenetics and Drug Metabolism (13 papers). Tausif Monif is often cited by papers focused on Analytical Methods in Pharmaceuticals (30 papers), Antibiotics Pharmacokinetics and Efficacy (22 papers) and Pharmacogenetics and Drug Metabolism (13 papers). Tausif Monif collaborates with scholars based in India, United States and Canada. Tausif Monif's co-authors include Arshad Khuroo, Saurabh Verma, Onkar Singh, Saurabh Saxena, P.L. Sharma, Sunil S. Iyer, P. R. P. Verma, Priya Ranjan Prasad Verma, Ajay Kumar and Jean‐Francois Marier and has published in prestigious journals such as Journal of Pharmaceutical and Biomedical Analysis, Journal of Chromatography B and Clinical Therapeutics.

In The Last Decade

Tausif Monif

84 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tausif Monif India 15 221 167 132 95 91 85 675
Arshad Khuroo India 14 197 0.9× 152 0.9× 119 0.9× 64 0.7× 96 1.1× 72 606
Bahareh Mohammadi Iran 17 251 1.1× 206 1.2× 132 1.0× 64 0.7× 139 1.5× 55 888
Marta Karaźniewicz‐Łada Poland 22 149 0.7× 214 1.3× 163 1.2× 63 0.7× 170 1.9× 72 1.2k
K.J Swart South Africa 18 261 1.2× 247 1.5× 241 1.8× 35 0.4× 100 1.1× 36 679
P. V. Macrae United Kingdom 11 205 0.9× 118 0.7× 197 1.5× 53 0.6× 107 1.2× 16 618
Don Farthing United States 20 235 1.1× 188 1.1× 165 1.3× 37 0.4× 245 2.7× 37 1.3k
Vikas V. Vaidya India 10 220 1.0× 111 0.7× 134 1.0× 34 0.4× 95 1.0× 46 479
Shuijun Li China 19 196 0.9× 119 0.7× 113 0.9× 47 0.5× 203 2.2× 48 872
Maria Paula Marques Brazil 17 151 0.7× 130 0.8× 186 1.4× 108 1.1× 81 0.9× 63 771
Dalia A. Hamdy Canada 14 114 0.5× 110 0.7× 74 0.6× 41 0.4× 94 1.0× 33 501

Countries citing papers authored by Tausif Monif

Since Specialization
Citations

This map shows the geographic impact of Tausif Monif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tausif Monif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tausif Monif more than expected).

Fields of papers citing papers by Tausif Monif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tausif Monif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tausif Monif. The network helps show where Tausif Monif may publish in the future.

Co-authorship network of co-authors of Tausif Monif

This figure shows the co-authorship network connecting the top 25 collaborators of Tausif Monif. A scholar is included among the top collaborators of Tausif Monif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tausif Monif. Tausif Monif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Khuroo, Arshad, et al.. (2014). Liquid chromatography–tandem mass spectrometry method for the estimation of adefovir in human plasma: Application to a pharmacokinetic study. Journal of Pharmaceutical Analysis. 5(3). 190–199. 4 indexed citations
3.
Khuroo, Arshad, et al.. (2012). Liquid chromatography tandem mass spectrometry method for the estimation of lamotrigine in human plasma: Application to a pharmacokinetic study. Journal of Pharmaceutical Analysis. 3(2). 75–83. 23 indexed citations
4.
Dey, Surajit, et al.. (2011). Establishing bioequivalence of racemic venlafaxine formulations using stereoselective assay method: Is it necessary?. Chirality. 23(10). 948–954. 9 indexed citations
5.
Samad, Abdus, Nilanjan Saha, Tausif Monif, P.L. Sharma, & K.K. Pillai. (2011). Pharmacokinetic-pharmacodynamic equivalence of three gliclazide formulations in healthy human male subjects. International Journal of Clinical Pharmacology and Therapeutics. 49(7). 444–450. 1 indexed citations
6.
Monif, Tausif, et al.. (2010). Validated Liquid chromatography tandem mass spectrometric method for quantification of Itraconazole and Hydroxy Itraconazolein human plasma for pharmacokinetic study. Der pharmacia lettre. 2(2). 41–53. 1 indexed citations
7.
Tassaneeyakul, Wichittra, Arshad Khuroo, Panot Tangsucharit, et al.. (2010). Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration. International Journal of Clinical Pharmacology and Therapeutics. 48(9). 614–620. 1 indexed citations
10.
Dubey, Sunil Kumar, et al.. (2009). Pharmacokinetics of 2-pyridyl acetic acid, a major betahistine metabolite in healthy Indian volunteers. Der pharmacia lettre. 1(2). 52–59. 2 indexed citations
11.
Khuroo, Arshad, et al.. (2009). Simultaneous determination of propranolol and 4-hydroxy propranolol in human plasma by solid phase extraction and liquid chromatography/electrospray tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 50(5). 966–976. 44 indexed citations
12.
Khuroo, Arshad, et al.. (2009). LC‐APCI mass spectrometric method development and validation for the determination of atovaquone in human plasma. Biomedical Chromatography. 24(5). 497–505. 6 indexed citations
13.
Reyer, Sebastian, et al.. (2008). Comparative bioavailability study with two pantoprazole delayed-released tablet formulations administered with and without food in healthy subjects. Americanae (AECID Library). 1 indexed citations
15.
Marier, Jean‐Francois, et al.. (2007). Pharmacokinetics of Lamivudine, Zidovudine, and Nevirapine Administered as a Fixed‐Dose Combination Formulation Versus Coadministration of the Individual Products. The Journal of Clinical Pharmacology. 47(11). 1381–1389. 18 indexed citations
16.
Marier, Jean‐Francois, Sied Kebir, Sara Ferrón, et al.. (2006). Comparative bioavailability study of zidovudine administered as two different tablet formulations in healthy adult subjects. International Journal of Clinical Pharmacology and Therapeutics. 44(5). 240–246. 7 indexed citations
18.
Monif, Tausif, et al.. (2006). Nevirapine/lamivudine/stavudine as a combined-formulation tablet: bioequivalence study compared with each component administered concurrently under fasting condition. International Journal of Clinical Pharmacology and Therapeutics. 44(6). 276–283. 1 indexed citations
19.
Parvez, Nayyar, Tausif Ahmed Rajput, Tausif Monif, Nilanjan Saha, & P.L. Sharma. (2004). Comparative bioavailability of three oral formulations of sustained release theophylline in healthy human subjects. Indian Journal of Pharmacology. 36(1). 29–33. 7 indexed citations
20.
Monif, Tausif, et al.. (1992). Cassia fistula seed galactomannan : potential binding agent for pharmaceutical formulation.. Indian Journal of Pharmaceutical Sciences. 54(6). 234. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026